8-K filing — STERIS plc (STE)
Filed: 2026-10-13 AccNo: 0001193125-26-420487 Size: 191 KB Item 1.01: Entry into a Material Definitive Agreement
Stocks · News reference
Steris (NYSE:STE) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts,
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-10-13 AccNo: 0001193125-26-420487 Size: 191 KB Item 1.01: Entry into a Material Definitive Agreement
STERIS plc announced a definitive agreement to acquire Xodus Medical, a specialty surgical products company, for $2.1 billion (net purchase price ~$1.8 billion after tax benefits). The acquisition is expected to close by December 31, 2026, and includes potential earnout consideration up to $150 million. Xodus Medical generated approximately $245 million in annual revenue for 2026 with $135 million in adjusted EBIT. STERIS expects the transaction to be accretive to top-line growth, margins, and adjusted earnings.
STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced that STERIS Corporation, a wholly owned subsidiary of the Company, has signed a definitive agreement to acquire Xodus Medical, Inc., a
ResearchAndMarkets.com released a comprehensive market report on China's sterilization equipment industry covering chemical, physical, and ultraviolet sterilizers. The report provides revenue, volume, and pricing data from 2018-2033, competitive analysis of major players, and strategic insights for market entry and expansion in this growing sector.